Affordable Access

Novel anti-diabetic agents in non-alcoholic fatty liver disease: a mini-review.

Authors
Type
Published Article
Journal
Hepatobiliary & pancreatic diseases international : HBPD INT
Publication Date
Volume
12
Issue
6
Pages
584–588
Identifiers
PMID: 24322742
Source
Medline
License
Unknown

Abstract

Liraglutide and Exenatide showed improvement in transaminases as well as histology in patients with NASH. Sitagliptin showed improvement in transaminases but limited studies are there to access its effect on histology. Further studies are needed to support use of newer anti-diabetic medications in patients with NAFLD.

Statistics

Seen <100 times